DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A (2014) Cancer treatment and survivorship statistics. CA Cancer J Clin 64(4):252–271

Article  PubMed  Google Scholar 

Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH (2007) Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25(25):3808–3815

Article  CAS  PubMed  Google Scholar 

Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD (2016) Cardiovascular disease mortality among breast cancer survivors. Epidemiology 27(1):6–13

Article  PubMed  PubMed Central  Google Scholar 

Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ (2007) ASCO Cancer Survivorship Expert Panel: American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 25(25):3991–4008

Article  CAS  PubMed  Google Scholar 

Demant EJ (1991) Inactivation of cytochrome c oxidase activity in mitochondrial membranes during redox cycling of doxorubicin. Biochem Pharmacol 41(4):543–552

Article  CAS  PubMed  Google Scholar 

Palmeira CM, Serrano J, Kuehl DW, Wallace KB (1997) Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin. Biochim Biophys Acta 1321:101–106

Article  CAS  PubMed  Google Scholar 

Mimnaugh EG, Trush MA, Bhatnagar M, Gram TE (1985) Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin. Biochem Pharmacol 34:847–856

Article  CAS  PubMed  Google Scholar 

Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F et al (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131:1981–1988

Article  CAS  PubMed  Google Scholar 

Cochet A, Quilichini G, Dygai-Cochet I, Touzery C, Toubeau M, Berriolo-Riedinger A et al (2011) Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer. Breast Cancer Res Treat 130:845–854

Article  CAS  PubMed  Google Scholar 

Faris R, Coats AJ, Henein MY (2002) Echocardiography-derived variables predict outcome in patients with nonischemic dilated cardiomyopathy with or without a restrictive filling pattern. Am Heart J 144:343–350

Article  PubMed  Google Scholar 

Shah AM, Claggett B, Sweitzer NK et al (2014) Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial. Circ Heart Fail 7:740–751

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kane GC, Karon BL, Mahoney DW et al (2011) Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 306:856–863

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reuvekamp EJ, Bulten BF, Nieuwenhuis AA, Meekes MR, de Haan AF, Tol J, Maas AH, Elias-Smale SE, de Geus-Oei LF (2016) Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA). J Nucl Cardiol 23(4):824–832

Article  CAS  PubMed  Google Scholar 

Lange SA, Ebner B, Wess A, Kögel M, Gajda M, Hitschold T, Jung J (2012) Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy. Clin Res Cardiol 101(6):415–426

Article  CAS  PubMed  Google Scholar 

Upshaw JN, Finkelman B, Hubbard RA, Smith AM, Narayan HK, Arndt L, Domchek S, DeMichele A, Fox K, Shah P, Clark A, Bradbury A, Matro J, Adusumalli S, Carver JR, Ky B (2020) Comprehensive assessment of changes in left ventricular diastolic function with contemporary breast cancer therapy. JACC Cardiovasc Imaging 13:198–210

Article  PubMed  Google Scholar 

Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ, Murphy RT (2010) Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 96(9):701–707

Article  CAS  PubMed  Google Scholar 

Serrano JM, Gonzalez I, Del Castillo S et al (2015) Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors. Oncologist 20:864–872

Article  CAS  PubMed  PubMed Central  Google Scholar 

Florescu M, Magda LS, Enescu OA, Jinga D, Vinereanu D (2014) Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer. J Am Soc Echocardiogr 27:83–92

Article  PubMed  Google Scholar 

Stoodley PW, Richards DA, Boyd A et al (2013) Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy. Eur Heart J Cardiovasc Imaging 14:228–234

Article  PubMed  Google Scholar 

Ganame J, Claus P, Eyskens B et al (2007) Acute cardiac functional and morphological changes after anthracycline infusions in children. Am J Cardiol 99:974–977

Article  CAS  PubMed  Google Scholar 

Calabrese V, Menna P, Annibali O et al (2018) Early Diastolic dysfunction after cancer chemotherapy: primary endpoint results of a multicenter cardiooncology study. Chemotherapy 63:55–56

Article  CAS  PubMed  Google Scholar 

Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 29(4):277–314

Article  PubMed  Google Scholar 

Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertension 71(6):e13–e115

CAS  PubMed  Google Scholar 

Anqi Y, Yu Z, Mingjun X et al (2019) Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy. Echocardiography 00:1–8

Google Scholar 

Boyd A, Stoodley P, Richards D et al (2017) Anthracyclines induce early changes in left ventricular systolic and diastolic function: a single centre study. PLoS ONE 12(4):e0175544

Article  PubMed  PubMed Central  Google Scholar 

Cochera F, Dinca D, Bordejevic DA, Citu I, Mavrea A, Andor M, Tomescu M (2018) Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer. Cancer Manag Res 2018(10):2071–2081

Article  Google Scholar 

Pathan F, D’Elia N, Nolan MT, Marwick TH, Negishi K (2017) Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. J Am Soc Echocardiogr 30(1):59-70.e8. https://doi.org/10.1016/j.echo.2016.09.007

Article  PubMed  Google Scholar 

Timóteo AT, Moura Branco L, Filipe F, Galrinho A, Rio P, Portugal G et al (2019) Cardiotoxicity in breast cancer treatment: What about left ventricular diastolic function and left atrial function? Echocardiography 36(10):1806–1813

Article  PubMed  Google Scholar 

Stoddard MF, Seeger J, Liddell NE et al (1992) Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol 2(1):62–69

Article  Google Scholar 

Marchandise B, Schroeder E, Bosly A et al (1989) Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart 118(1):92–98

Article  CAS  Google Scholar 

Van Boxtel CJ, Olson RD, Boerth RC et al (1978) Doxorubicin: inotropic effects and inhibitory action on ouabain. J Pharmacol Exp Ther 207(2):277–283

PubMed  Google Scholar 

Gosálvez M, van Rossum GD, Blanco MF (1979) Inhibition of sodium-potassium-activated adenosine 5′-triphosphatase and ion transport by adriamycin. Cancer Res 39(1):257–261

PubMed  Google Scholar 

Zarka AM, Riyaz AM et al (2016) Prevalence and determinants of hypertension in Kashmir: a cross sectional study. IOSR J Dent Med Sci IOSR-JDMS 15(6):57–64

Google Scholar 

Mathur P, Leburu S, Kulothungan V (2022) Prevalence, awareness, treatment and control of diabetes in India from the countrywide national NCD monitoring survey. Front Public Health 14(10):748157

Article  Google Scholar 

ShanK LAM, Young JB (1996) Anthracycline induced cardiotoxicity. Ann Intern Med 125:47–58

Article  Google Scholar 

VonHoff DD, Layard MW, Petal B (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710–717

Article  CAS  Google Scholar 

Fumoleau P, Roche H, Kerbrat P et al (2006) Long term cardiac toxicity after adjuvant epirubicin based chemotherapy in early breast cancer: French Adjuvant Study Group results. Ann Oncol 17:85–92

Article  CAS  PubMed  Google Scholar 

Dranitsaris G, Rayson D, Vincent M et al (2008) The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines. Breast Cancer Res Treat 107:443–450

Article  CAS  PubMed  Google Scholar